| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.009 |